Westminster, CA , Aug. 22, 2017 (GLOBE NEWSWIRE) -- BioLargo, Inc., (OTCQB: BLGO; www.biolargo.com), a sustainable science and technology company that delivers practical
solutions for clean water, clean air and advanced wound care, announced in a blog post yesterday highlights from its 3rd annual technical symposium held at the
Snow Valley Conference Center in Edmonton Alberta. The blog post, found here, included highlights regarding the successful tests conducted by a leading water
engineering firm of BioLargo’s AOS system on industry-provided water, potential scalable designs of the AOS system to handle
increased water flow in commercial settings, and a solar powered “AOS Mini” demonstrating the low power and flexibility of the AOS
system in a design that could potentially provide clean water to extremely water-scarce or disaster-prone areas.
The company promises further updates and developments of its AOS and technical achievements in future blog posts.
About BioLargo, Inc.
BioLargo, Inc. is a sustainable science and technology company that makes life better by delivering award-winning products for
clean water, clean air and advanced wound care. More information can be found about the company and its subsidiaries
at www.BioLargo.com. Its subsidiary BioLargo Water, Inc. (www.BioLargoWater.com) showcases its emerging technology, the Advanced Oxidation System “AOS”,
an award-winning product, having been awarded more than 35 research grants and counting, specifically designed to eliminate common,
troublesome, and dangerous (toxic) contaminants in water in a fraction of the time and cost of current technologies. BioLargo's
subsidiary Odor-No-More Inc., features sustainable odor elimination products including its CupriDyne Clean (www.CupriDyne.com) Industrial Odor Eliminator, a product currently serving the leading solid
waste handling and wastewater treatment companies as well as any industry that must contend with malodors, VOC’s or similar air
quality related problems. Its personal care products are finding adoption through white labeling or early market entry in the pet,
equine, military supply and consumer markets, and include the Nature's Best Solution® and Deodorall® brands (www.OdorNoMore.com). BioLargo's subsidiary Clyra Medical Technologies, Inc. (www.ClyraMedical.com) focuses on advanced wound care management featuring effective and gentle
solutions for chronic infected wounds and other uses to promote infection control. BioLargo also owns a 50% interest in the Isan
System, a fully automated iodine dosing system being commercialized under a license to Clarion Water, Inc.
Safe Harbor Statement
The statements contained herein, which are not historical, are forward-looking statements that are subject to risks and
uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements,
including, but not limited to, the risks and uncertainties included in BioLargo's current and future filings with the Securities
and Exchange Commission, including those set forth in BioLargo's Annual Report on Form 10-K.
Source: Uptick Newswire
Contact: Company Contact Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540 x2
